Metrics as of 10/16/2026, 06:26 AM (Berlin time), refresh in progress.
Accuray Stock
Accuray Incorporated
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Stephen R. LaNeve
- Employees
- 809
- Market cap
- $21 M
- IPO
- 08/02/2007
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader…
Accuray stock: price history
1D
-0.7%
1W
-28.0%
1M
-24.6%
6M
-61.0%
YTD
-78.9%
1Y
-90.4%
2Y
-90.7%
5Y
-95.6%
10Y
-96.9%
Next earnings date
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~125% stronger price swings than usual
Ask the agents about Accuray
Analyst assessment of Accuray
PRICE TARGET LOW
US$2.00
CONSENSUS
US$2.00
MEDIAN
US$2.00
PRICE TARGET HIGH
US$2.00
0
STRONG BUY
8
BUY
4
HOLD
1
SELL
0
STRONG SELL
13
TOTAL · Buy
As of: 12/05/2026
Accuray stock metrics
P/E
-0.44
P/B
0.51
EV/EBITDA
-25.62
RETURN ON EQUITY
-4.7%
NET MARGIN
-1.9%
DEBT/EQUITY
4.41
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
95.1%
FLOAT SHARES
113,610,669
AVG. DAILY VOLUME (30D)
14,265,777
Insider transactions (SEC)
Pervaiz Ali
Pervaiz Ali
Institutional holders
Comparable stocks
Frequently asked questions about Accuray stock
What does Accuray do?
Accuray Incorporated is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Stephen R. LaNeve, the company employs around 809 people.
The IPO was on 08/02/2007; the stock trades on NASDAQ under the ticker ARAY.
What do analysts say about Accuray stock?
13 analysts rate the stock, the consensus is Buy (as of 12/05/2026).
The average price target is US$2.00, ranging from US$2.00 to US$2.00, with a median of US$2.00.
This is an external assessment, not a statement by Market Jury.
When does Accuray report next?
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 125% stronger than usual.
Does Accuray pay a dividend?
No, Accuray currently does not pay a dividend.
Which stocks are comparable to Accuray?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Accuray stock analyzed?
Clicking "Analyze stock" lets five strategies assess Accuray against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.